Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$18,432,630
+$2,614,583 QoQ
Shares Held
73,250
+0.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.49%
of 13F equity value
Holder Rank
#644
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PAYDEN & RYGEL holds $102,478,534 across 7 Drug Manufacturers - General names. ABBV ranks #2 (18.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
200,960 | $25,823,360 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
73,250 | $18,432,630 | |
| 3 | LLY |
ELI LILLY & Co
|
14,670 | $17,595,639 | |
| 4 | JNJ |
Johnson & Johnson
|
64,900 | $16,482,653 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
126,560 | $15,989,590 | |
| 6 | PFE |
Pfizer Inc
|
311,580 | $7,502,846 | |
| 7 | AMGN |
Amgen Inc
|
1,800 | $651,816 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,432,630 | 73,250 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $15,818,047 | 72,730 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $13,026,214 | 57,010 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $13,292,711 | 57,410 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $20,418 | 110 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $10,687,615 | 51,010 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $19,547 | 110 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $989,374 | 5,010 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $859,315 | 5,010 | Shares | Sole | 2024-10-07 | |
| 2024-03-31 | $912,321 | 5,010 | Shares | Sole | 2024-10-08 | |
| 2023-12-31 | $776,399 | 5,010 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $746,790 | 5,010 | Shares | Sole | 2024-10-07 | |
| 2023-06-30 | $16,536,760 | 122,740 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $23,640,945 | 148,340 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $33,658,514 | 208,270 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $33,696,104 | 251,070 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $37,764,661 | 246,570 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $34,508,355 | 212,870 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $47,445,514 | 350,410 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $30,306,076 | 280,950 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $21,604,352 | 191,800 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $24,371,144 | 225,200 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $22,737,230 | 212,200 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $18,884,404 | 215,600 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $20,470,530 | 208,500 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $15,885,615 | 208,500 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||